{"id":"https://openalex.org/W3110693464","doi":"https://doi.org/10.1016/s2152-2650(20)30699-6","title":"ALL-406: Comparison of Safe Delivery of 2 and 5 g/m2 of High-Dose Methotrexate to Children with Acute Lymphoblastic Leukemia in Sri Lanka without Availability of Methotrexate Levels","display_name":"ALL-406: Comparison of Safe Delivery of 2 and 5 g/m2 of High-Dose Methotrexate to Children with Acute Lymphoblastic Leukemia in Sri Lanka without Availability of Methotrexate Levels","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3110693464","doi":"https://doi.org/10.1016/s2152-2650(20)30699-6","mag":"3110693464"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(20)30699-6","doi":"https://doi.org/10.1016/s2152-2650(20)30699-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(20)30699-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067977271","display_name":"Sanjeeva Gunasekera","orcid":"https://orcid.org/0000-0002-4043-559X","observed_orcids":["https://orcid.org/0000-0002-4043-559X"]},"institutions":[{"id":"https://openalex.org/I4210138488","display_name":"National Cancer Institute of Sri Lanka","ror":"https://ror.org/04zymc478","country_code":"LK","type":"healthcare","lineage":["https://openalex.org/I4210138488"]}],"countries":["LK"],"is_corresponding":false,"raw_author_name":"Sanjeeva Gunasekera","raw_affiliation_strings":["National Cancer Institute Sri Lanka, Colombo, Sri Lanka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute Sri Lanka, Colombo, Sri Lanka","institution_ids":["https://openalex.org/I4210138488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001150913","display_name":"Geeth Vindula","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138488","display_name":"National Cancer Institute of Sri Lanka","ror":"https://ror.org/04zymc478","country_code":"LK","type":"healthcare","lineage":["https://openalex.org/I4210138488"]}],"countries":["LK"],"is_corresponding":false,"raw_author_name":"Geeth Vindula","raw_affiliation_strings":["National Cancer Institute Sri Lanka, Colombo, Sri Lanka"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute Sri Lanka, Colombo, Sri Lanka","institution_ids":["https://openalex.org/I4210138488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059039010","display_name":"Ryan Combs","orcid":"https://orcid.org/0000-0001-8795-4859","observed_orcids":["https://orcid.org/0000-0001-8795-4859"]},"institutions":[{"id":"https://openalex.org/I4387153510","display_name":"Resonance (United States)","ror":"https://ror.org/044ze3t60","country_code":"US","type":"company","lineage":["https://openalex.org/I4387153510"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Combs","raw_affiliation_strings":["Resonance, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Resonance, Memphis, TN, USA","institution_ids":["https://openalex.org/I4387153510"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011622752","display_name":"Scott C. Howard","orcid":"https://orcid.org/0000-0003-2244-1686","observed_orcids":["https://orcid.org/0000-0003-2244-1686"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Howard","raw_affiliation_strings":["University of Tennessee Health Science Center, Memphis, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Tennessee Health Science Center, Memphis, TN, USA","institution_ids":["https://openalex.org/I160606119"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":1900,"currency":"USD","value_usd":1900},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":null,"first_page":"S172","last_page":"S172"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/high-dose-methotrexate","display_name":"high-dose methotrexate","score":0.8560000061988831},{"id":"https://openalex.org/keywords/pediatric-chemotherapy","display_name":"pediatric chemotherapy","score":0.6830000281333923},{"id":"https://openalex.org/keywords/methotrexate-toxicity","display_name":"methotrexate toxicity","score":0.781000018119812},{"id":"https://openalex.org/keywords/mucositis","display_name":"mucositis","score":0.9649999737739563},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.9890000224113464},{"id":"https://openalex.org/keywords/low-and-middle-income-countries","display_name":"low- and middle-income countries","score":0.7929999828338623},{"id":"https://openalex.org/keywords/sri-lanka","display_name":"Sri Lanka","score":0.8009999990463257},{"id":"https://openalex.org/keywords/treatment-delay","display_name":"treatment delay","score":0.4790000021457672},{"id":"https://openalex.org/keywords/nursing-shortage","display_name":"nursing shortage","score":0.46299999952316284},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.6010000109672546},{"id":"https://openalex.org/keywords/infection","display_name":"infection","score":0.42500001192092896},{"id":"https://openalex.org/keywords/hemorrhage","display_name":"hemorrhage","score":0.8420000076293945},{"id":"https://openalex.org/keywords/resource-limited-settings","display_name":"resource-limited settings","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9370455145835876},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7470431327819824},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.6983876824378967},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5809994339942932},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5036479830741882},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.37526971101760864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36699509620666504},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(20)30699-6","doi":"https://doi.org/10.1016/s2152-2650(20)30699-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(20)30699-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3136471464","https://openalex.org/W2141998397","https://openalex.org/W2507407134","https://openalex.org/W2368828490","https://openalex.org/W1959353134","https://openalex.org/W2950586452","https://openalex.org/W3092117253","https://openalex.org/W2803165542","https://openalex.org/W3080518003","https://openalex.org/W6987738420"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2020-12-21T00:00:00"}